0001213900-20-016303.txt : 20200630 0001213900-20-016303.hdr.sgml : 20200630 20200630160830 ACCESSION NUMBER: 0001213900-20-016303 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190905 FILED AS OF DATE: 20200630 DATE AS OF CHANGE: 20200630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zarrabian Saiid CENTRAL INDEX KEY: 0001495521 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37823 FILM NUMBER: 201002414 MAIL ADDRESS: STREET 1: P.O. BOX 675765 CITY: RANCHO SANTA FE STATE: CA ZIP: 92067 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DelMar Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001498382 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 990360497 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 12707 HIGH BLUFF DR., SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 350-4364 MAIL ADDRESS: STREET 1: 12707 HIGH BLUFF DR., SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: Berry Only Inc. DATE OF NAME CHANGE: 20100805 4 1 ownership.xml X0306 4 2019-09-05 0 0001498382 DelMar Pharmaceuticals, Inc. DMPI 0001495521 Zarrabian Saiid 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 1 1 0 0 President and CEO Options (Right to Buy) 0.61 2020-06-26 4 A 0 241438 0 A 2029-09-05 Common Stock 241438 457650 D On September 5, 2019, the reporting person received options to purchase 241,438 shares which were subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the 2020 Annual Meeting of Stockholders. Stockholder approval of the increase was obtained on June 26, 2020. 1/6th of the options vested on March 5, 2020 with the remaining shares vesting in equal monthly installments over a period of 30 months commencing on April 5, 2020. /s/ Anthony Scott Praill, attorney-in-fact for Saiid Zarrabian 2020-06-30